BAS
0.081
138.2%
PIL
0.003
-25%
AM5
0.012
33.3%
OVT
0.004
-20%
CHM
0.004
33.3%
NVA
1.105
-15.3%
YAR
0.011
22.2%
APC
0.013
-13.3%
MRR
0.013
18.2%
THL
1.95
-12.6%
NVQ
0.026
18.2%
AON
0.008
-11.1%
VAR
0.007
16.7%
MAY
0.008
-11.1%
NH3
0.105
15.4%
COB
0.094
-10.5%
FAU
0.008
14.3%
AAU
0.009
-10%
CRR
0.009
12.5%
SLZ
0.009
-10%
EDE
0.054
12.5%
ASL
1.905
-8.9%
AEI
0.055
12.2%
LKY
0.27
-8.5%
LML
0.01
11.1%
CLA
0.011
-8.3%
LPM
0.16
10.3%
SMX
0.022
-8.3%
SLD
1.4
10.2%
PEN
0.48
-7.7%
IMU
0.35
9.4%
OD6
0.074
-7.5%
AGD
0.1
8.7%
RCM
0.05
-7.4%
RLF
0.076
8.6%
HWK
0.028
-6.7%
AEU
0.39
8.3%
RCR
0.014
-6.7%
CEL
0.135
8%
CHN
1.635
-6.6%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH